English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

1. Parvin A A, A RP, U S, Devendran A, Baker JE, et al. (2014) Erythropoietin Protects Cardiomyocytes from Cell Death during Hypoxia/Reperfusion Injury through Activation of Survival Signaling Pathways. PLoS ONE 9(9): e107453. doi:10.1371/journal.pone.0107453 Figure 2. Pre-treatment of EPO increases cell viability in H/R induced H9C2 cells. The effect of EPO on cell viability was determined using MTT assay. H9C2 cells were subjected to H/R with or without pre-treatment with (10 U/ml, 15 U/ml and 20 U/ml) EPO for 24 hrs. 20 U/ml EPO significantly increases cell viability after H/R. Data are presented as means 6 SEM of the ratios from five independent experiments. denotes p,0.05, & denotes p,0.01, * denotes p,0.001 for analyses compared to H/R. doi:10.1371/journal.pone.0107453.g002

Correction: Erythropoietin Protects Cardiomyocytes from Cell Death during Hypoxia/Reperfusion Injury through Activation of Survival Signaling Pathways